To further investigate the impact of changes in CSGALNACT2 gene expression on other ovarian cancer cell lines, two shRNA-targeted CSGALNACT2 and overexpression plasmids of CSGALNACT2 were designed and transfected into A2780 cell (Fig. 3O). This evidence concerns the gene CSGALNACT2 and ovarian cancer.